Skip to main content

Alnylam Promotes Greene to President, Zubarev Joins Sage-N-Research's SAB, Cellzome Appoints SAB Members

NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals has promoted Barry Greene from COO to president and COO, the firm announced today. He will continue to report to CEO John Maraganore. Prior to Alnylam, Greene was general manager of oncology at Millennium Pharmaceuticals.

Roman Zubarev has joined Sage-N Research’s scientific advisory board. Zubarev, a professor at Sweden’s Uppsala University, specializes in proteomics, pathway analysis, and mass spectrometry research.

Cellzome this week said it has appointed the members of its scientific advisory board and has named company CSO David Simmons to chair the SAB.
The newly appointed SAB includes:
Spyros Artavanis-Tsakonas, a professor of cell biology at Harvard Medical School and at the College of France;
Christopher Buckley, who is professor of rheumatology at the MRC Centre for Immune Regulation, University of Birmingham;
Sir Philip Cohen, director of the Medical Research Council Protein Phosphorylation Unit at the University of Dundee;
Emilio Hirsch, a professor of applied biology at the Center for Molecular Biotechnology at the University of Torino;
Harren Jhoti, who is founder and CEO of Astex Therapeutics;
Bernhard Kuster, a professor of bioanalytics at the Technical University Munich;
David Middlemiss, founder of the drug discovery consulting company XaviaPharm;
David Sabatini, principal investigator at the Whitehead Institute for Biomedical Research;
Giulio Supert-Furga, who is director of the Center of Molecular Medicine at the Austrian Academy of Sciences;
Arthur Weiss, who is an Ephraim Engleman Distinguished Professor of Rheumatology and is a professor of medicine, microbiology and immunology at the University of California.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.